Role of autologous platelet-rich plasma in treatment of long-bone nonunions: a prospective study

Musculoskeletal Surgery

Volumn 99, Issue 3, 2015, Pages 243-248

  Malhotra, R ^a   Kumar, V ^a   Garg, B ^a   Singh, R ^a   Jain, V ^a   Coshic, P ^a   Chatterjee, K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Femur; Humerus; Nonunion; Platelet rich plasma (PRP); Radius; Tibia

Indexed keywords

DIAGNOSTIC IMAGING; FEMALE; FEMORAL FRACTURES; FOLLOW UP; FRACTURE HEALING; FRACTURES, BONE; FRACTURES, UNUNITED; HUMAN; HUMERAL FRACTURES; MALE; PATIENT SATISFACTION; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIUS FRACTURES; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE RICH PLASMA; TIBIAL FRACTURES; TREATMENT OUTCOME; ULNA FRACTURES;

FEMALE; FEMORAL FRACTURES; FOLLOW-UP STUDIES; FRACTURE HEALING; FRACTURES, BONE; FRACTURES, UNUNITED; HUMANS; HUMERAL FRACTURES; INJECTIONS, SUBCUTANEOUS; MALE; PATIENT SATISFACTION; PLATELET-RICH PLASMA; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIUS FRACTURES; TIBIAL FRACTURES; TREATMENT OUTCOME; ULNA FRACTURES;

EID: 84947433956     PISSN: 20355106     EISSN: 20355114     Source Type: Journal    
DOI: 10.1007/s12306-015-0378-8     Document Type: Article

References (48)

1. Bauer TW, Muschler GF (2000) Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 371:10–27
2. Fleming JE Jr, Cornell CN, Muschler GF (2000) Bone cells and matrices in orthopedic tissue engineering. Orthop Clin North Am 31(3):357–374
3. Giannoudis PV, Dinopoulos H, Tsiridis E (2005) Bone substitutes: an update. Injury 36(Suppl 3):S20–S27
4. Finkemeier CG (2002) Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am 84-A(3):454–464
5. Saikia KC, Bhattacharya TD, Bhuyan SK, Talukdar DJ, Saikia SP, Jitesh P (2008) Calcium phosphate ceramics as bone graft substitutes in filling bone tumor defects. Indian J Orthop 42(2):169–172
6. Younger EM, Chapman MW (1989) Morbidity at bone graft donor sites. J Orthop Trauma 3(3):192–195
7. Sánchez AR, Sheridan PJ, Kupp LI (2003) Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 18(1):93–103
8. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998) Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 85(6):638–646
9. Harrison P, Cramer EM (1993) Platelet alpha-granules. Blood Rev 7(1):52–62
10. Bucholz RW, Einhorn TA, Marsh JL (2006) Bone and joint healing. In: Bucholz RW, Heck-man JD, Court-Brown C (eds) Rockwood & Green’s fractures in adults, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 300–311
11. Schilephake H (2002) Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31(5):469–484
12. Mehta S, Watson JT (2008) Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma 22(6):432–438
13. Gandhi A, Doumas C, Dumas C, O’Connor JP, Parsons JR, Lin SS (2006) The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 38(4):540–546
14. Wilkins RM, Chimenti BT, Rifkin RM (2003) Percutaneous treatment of long bone nonunions: the use of autologous bone marrow and allograft bone matrix. Orthopedics 26(5 Suppl):s549–s554
15. Heckman JD, Ryaby JP, McCabe J, Frey JJ, Kilcoyne RF (1994) Acceleration of tibial fracture-healing by non-invasive, low-intensity pulsed ultrasound. J Bone Joint Surg Am 76(1):26–34
16. Corrales LA, Morshed S, Bhandari M, Miclau T 3rd (2008) Variability in the assessment of fracture-healing in orthopaedic trauma studies. J Bone Joint Surg Am 90(9):1862–1868
17. Wilkins RM, Kelly CM (2003) The effect of allomatrix injectable putty on the outcome of long bone applications. Orthopedics 26(5 Suppl):s567–s570
18. Simpson AHRW, Mills L, Noble B (2006) The role of growth factors and related agents in accelerating fracture healing. J Bone Joint Surg Br 88(6):701–705
19. Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV (2005) Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 36(Suppl 4):S51–S59
20. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF et al (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A(Suppl 1(Pt 2)):S151–S158
21. Goel A, Sangwan SS, Siwach RC, Ali AM (2005) Percutaneous bone marrow grafting for the treatment of tibial non-union. Injury 36(1):203–206
22. Connolly JF (1995) Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res 313:8–18
23. Healey JH, Zimmerman PA, McDonnell JM, Lane JM (1990) Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 256:280–285
24. Hernigou P, Poignard A, Beaujean F, Rouard H (2005) Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 87(7):1430–1437
25. Mishra A, Pavelko T (2006) Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 34(11):1774–1778
26. Bielecki TM, Gazdzik TS (2006) Percutaneous injection of autogenous growth factors in patient with nonunion of the humerus. A case report. J Orthop 3(3):15
27. Calori GM, D’Avino M, Tagliabue L, Albisetti W, d’ Imporzano M, Peretti G (2006) An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results. Injury 37(Suppl 3):S43–S50
28. Fréchette J-P, Martineau I, Gagnon G (2005) Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 84(5):434–439
29. George JN (2000) Platelets. Lancet 355(9214):1531–1539
30. Slater M, Patava J, Kingham K, Mason RS (1995) Involvement of platelets in stimulating osteogenic activity. J Orthop Res 13(5):655–663
31. Dallari D, Fini M, Stagni C, Torricelli P, Nicoli Aldini N, Giavaresi G et al (2006) In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res 24(5):877–888
32. Lind M (1998) Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. Acta Orthop Scand Suppl 283:2–37
33. Beck LS, Amento EP, Xu Y, Deguzman L, Lee WP, Nguyen T et al (1993) TGF-beta 1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-beta 1. J Bone Miner Res 8(6):753–761
34. Nielsen HM, Andreassen TT, Ledet T, Oxlund H (1994) Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 65(1):37–41
35. Whitman DH, Berry RL, Green DM (1997) Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55(11):1294–1299
36. Anitua E (1999) Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 14(4):529–535
37. Lowery GL, Kulkarni S, Pennisi AE (1999) Use of autologous growth factors in lumbar spinal fusion. Bone 25(2 Suppl):47S–50S
38. Parsons P, Butcher A, Hesselden K, Ellis K, Maughan J, Milner R et al (2008) Platelet-rich concentrate supports human mesenchymal stem cell proliferation, bone morphogenetic protein-2 messenger RNA expression, alkaline phosphatase activity, and bone formation in vitro: a mode of action to enhance bone repair. J Orthop Trauma 22(9):595–604
39. Gandhi A, Bibbo C, Pinzur M, Lin SS (2005) The role of platelet-rich plasma in foot and ankle surgery. Foot Ankle Clin 10(4):621–637
40. Bielecki T, Gazdzik TS, Szczepanski T (2008) Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur Surg Res 40(3):289–296
41. Ogino Y, Ayukawa Y, Kukita T, Koyano K (2006) The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(6):724–729
42. Bielecki T, Gazdzik TS, Szczepanski T (2006) Re: “The effects of local platelet rich plasma delivery on diabetic fracture healing”. What do we use: platelet-rich plasma or platelet-rich gel? Bone 39(6):1388; author reply 1389
43. Alsousou J, Thompson M, Hulley P, Noble A, Willett K (2009) The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 91(8):987–996
44. Lomax C, Traub O (2009) Topical thrombins: benefits and risks. Pharmacotherapy 29(7 Pt 2):8S–12S
45. Di Matteo B, Filardo G, Kon E, Marcacci M (2015) Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy—a systematic review. Musculoskelet Surg 99(1):1–9
46. Turajane T, Thitiset T, Honsawek S, Chaveewanakorn U, Aojanepong J, Papadopoulos KI (2014) Assessment of chondrogenic differentiation potential of autologous activated peripheral blood stem cells on human early osteoarthritic cancellous tibial bone scaffold. Musculoskelet Surg 98(1):35–43
47. Gonshor A (2002) Technique for producing platelet-rich plasma and platelet concentrate: background and process. Int J Periodontics Restor Dent 22(6):547–557
48. Say F, Türkeli E, Bülbül M (2014) Is platelet-rich plasma injection an effective choice in cases of non-union? Acta Chir Orthop Traumatol Cech 81(5):340–345